kabutan

Sumitomo Pharma, 28% Decrease in Net Income for The Current Fiscal Year

Wed May 13, 2026 1:00 pm JST Earnings

4506 Sumitomo Pharma Co., Ltd. 【IFRS】

Earnings Report

Sumitomo Pharma Co., Ltd. <4506> [TSE Prime] announced its financial results (based on IFRS) in the afternoon session on May 13th (13:00). The consolidated net income for the fiscal year ended March 2026 expanded to 4.5 times that of the previous period to 106 billion yen. However, for the fiscal year ending March 2027, the consolidated net income is expected to decrease by 27.9% from the previous period to 77.0 billion yen.

At the same time, the company has left the annual dividend for the current term undetermined.

In the most recent three-month period, from January to March (4Q), the consolidated net income/loss turned to a loss of 0.81 billion yen (compared to a profit of 2.41 billion yen in the same period last year). The operating profit/loss margin drastically worsened from 14.7% in the same period last year to -2.3%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 314,558 -354,859 -323,114 -314,969 -792.8 0 May 14, 2024 IFRS
Mar, 2025 398,832 28,804 17,611 23,634 59.5 0 May 13, 2025 IFRS
Mar, 2026 453,294 107,338 100,344 106,865 269.0 0 May 13, 2026 IFRS
YoY +13.7% +272.6% +469.8% +352.2% +352.2%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Guidance 449,000 108,000 ー 102,000 256.7 0 Mar 2, 2026 IFRS
Mar, 2026 Results 453,294 107,338 100,344 106,865 269.0 0 May 13, 2026 IFRS
Revision Rate +1.0% -0.6% － +4.8% +4.8%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 227,122 96,157 92,802 98,860 248.8 0 Oct 31, 2025 IFRS
Apr - Sep, 2026 Guidance ー ー ー ー － － May 13, 2026 IFRS
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 398,832 28,804 17,611 23,634 59.5 0 May 13, 2025 IFRS
Mar, 2026 453,294 107,338 100,344 106,865 269.0 0 May 13, 2026 IFRS
Mar, 2027 Guidance 540,000 90,000 ー 77,000 171.7 － May 13, 2026 IFRS
YoY +19.1% -16.2% － -27.9% -36.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2025 105,649 15,578 -6,415 2,415 6.1 14.7 May 13, 2025 IFRS
Apr - Jun, 2025 108,002 20,400 11,932 11,206 28.2 18.9 Jul 31, 2025 IFRS
Jul - Sep, 2025 119,120 75,757 80,870 87,654 220.6 63.6 Oct 31, 2025 IFRS
Oct - Dec, 2025 120,624 13,617 8,737 8,817 22.2 11.3 Jan 30, 2026 IFRS
Jan - Mar, 2026 105,548 -2,436 -1,195 -812 -2.0 -2.3 May 13, 2026 IFRS
YoY -0.1% － +81.4% － －

Related Articles